These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 15206668)

  • 61. Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities.
    Sánchez C; Bergqvist PB; Brennum LT; Gupta S; Hogg S; Larsen A; Wiborg O
    Psychopharmacology (Berl); 2003 Jun; 167(4):353-62. PubMed ID: 12719960
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Second generation SSRIS: human monoamine transporter binding profile of escitalopram and R-fluoxetine].
    Owens JM; Knight DL; Nemeroff CB
    Encephale; 2002; 28(4):350-5. PubMed ID: 12232544
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors.
    Chen F; Larsen MB; Sánchez C; Wiborg O
    Eur Neuropsychopharmacol; 2005 Mar; 15(2):193-8. PubMed ID: 15695064
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacological characterization of the cloned human 5-hydroxytryptamine transporter.
    Agnel M; Esnaud H; Langer SZ; Graham D
    Biochem Pharmacol; 1996 May; 51(9):1145-51. PubMed ID: 8645336
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The pharmacology of citalopram enantiomers: the antagonism by R-citalopram on the effect of S-citalopram.
    Sánchez C
    Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):91-5. PubMed ID: 16918708
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Improved potency of escitalopram on the human serotonin transporter: demonstration of an ex vivo assay technique.
    Rausch JL; Corley KM; Hobby HM
    J Clin Psychopharmacol; 2004 Apr; 24(2):209-13. PubMed ID: 15206668
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Escitalopram, an antidepressant with an allosteric effect at the serotonin transporter--a review of current understanding of its mechanism of action.
    Zhong H; Haddjeri N; Sánchez C
    Psychopharmacology (Berl); 2012 Jan; 219(1):1-13. PubMed ID: 21901317
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Structure, function and regulation of the 5-hydroxytryptamine (serotonin) transporter.
    Horschitz S; Hummerich R; Schloss P
    Biochem Soc Trans; 2001 Nov; 29(Pt 6):728-32. PubMed ID: 11709064
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Escitalopram: a review of its use in the management of anxiety disorders.
    Dhillon S; Scott LJ; Plosker GL
    CNS Drugs; 2006; 20(9):763-90. PubMed ID: 16953656
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Escitalopram and citalopram: the unexpected role of the R-enantiomer].
    Jacquot C; David DJ; Gardier AM; Sánchez C
    Encephale; 2007; 33(2):179-87. PubMed ID: 17675913
    [TBL] [Abstract][Full Text] [Related]  

  • 71.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.